ANDOVER, Mass., Nov. 13, 2018 /PRNewswire/ -- Ora ® Inc. has been retained by ProQR Therapeutics to provide standardized mobility test services for ProQR's Phase 3 development program for Leber's ...

BOSTON--(BUSINESS WIRE)--Ora, Inc., the world’s leading Clinical Research Organization (CRO) for ophthalmology pharmaceutical and device development, announced today that Paul Colvin has been ...

BOSTON--(BUSINESS WIRE)--Ora, Inc., the world’s leading CRO partner for ophthalmic pharmaceutical and device development, announced today that it has appointed Lori Helgeson as the Senior ...

2024 /PRNewswire/ -- Ora, Inc., the world's leading partner for ophthalmic pharmaceutical and device development, today announced its participation as a major exhibitor in the Association for ...

The History of Parliament Trust unveils new publication at Palace of Westminster BOSTON, September 06, 2023--(BUSINESS WIRE)--Ora, Inc., the world’s leading Clinical Research Organisation (CRO ...

BOSTON--(BUSINESS WIRE)--#ARVO2023--Ora, Inc. supports eye care innovators across every phase of drug and device development to help bring their life-changing therapies to patients. Completely ...